e-learning
resources
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
De-labelling severe asthma diagnosis: the challenge of DIPNECH
Caroline Hurabielle, Camille Taillé, Grégoire Prévot, Maud Russier, Alain Didier, Pierre-Olivier Girodet, Magali Colombat, Julien Mazières, Laurent Guilleminault
Source:
ERJ Open Res, 8 (1) 00485-2021; 10.1183/23120541.00485-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Caroline Hurabielle, Camille Taillé, Grégoire Prévot, Maud Russier, Alain Didier, Pierre-Olivier Girodet, Magali Colombat, Julien Mazières, Laurent Guilleminault. De-labelling severe asthma diagnosis: the challenge of DIPNECH. ERJ Open Res, 8 (1) 00485-2021; 10.1183/23120541.00485-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
When asthma diagnosis becomes a challenge
Source: Eur Respir J 2010; 36: 231
Year: 2010
Severe asthma: approach to diagnosis and treatment
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Severe asthma: classification and treatment
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Specific nasal challenge in the diagnosis of alternaria-induced asthma
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
Re-evaluation of asthma diagnosis in patients with adult-onset asthma
Source: International Congress 2017 – New research in asthma and COPD
Year: 2017
Immunotherapy in severe asthma
Source: ERS webinar 2021: Immunotherapy in severe asthma
Year: 2021
Bronchiectasis as a serious problem in children: ethiology, diagnosis and symptoms
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004
Evolution from mild to severe asthma; the severe asthma clinic perspective
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults
Source: Eur Respir J 2007; 30: Suppl. 51, 587s
Year: 2007
Defining asthma and COPD: differential diagnosis
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018
Nasal symptoms and doctor-diagnosed chronic lung diseases
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
The challenge of defining exacerbation in bronchiectasis
Source: Eur Respir J, 49 (6) 1700700; 10.1183/13993003.00700-2017
Year: 2017
Anti-IL5 therapy could prevent lung function decline in severe eosinophilic asthma: data from the belgian severe asthma registry
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Severe asthma: one disease many definitions
Source: International Congress 2019 – Asthma and the world
Year: 2019
Diagnostic value of specific nasal provocation in the diagnosis of allergic rhinitis in mild persistent asthma cases
Source: Eur Respir J 2002; 20: Suppl. 38, 218s
Year: 2002
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept